Clayman & Rosenberg LLP has long been known for its expertise in successfully guiding clients through the complex and sensitive issues associated with white-collar criminal matters.  Our practice in this area takes our attorneys to federal, state and local courts nationwide and often international destinations, most recently to England, Ireland, Germany, Japan and Singapore.

Our depth of experience and sophisticated judgment facilitates the skillful representation of individuals and business entities facing a broad range of criminal charges, including securities fraud, mail and wire fraud, bank fraud, conspiracy, insider trading, money laundering, health care and insurance fraud, commercial bribery, OFAC and Economic Sanctions, RICO violations, enterprise corruption, embezzlement, larceny, perjury, obstruction of justice and violations of the Foreign Corrupt Practices Act (FCPA).  Clayman & Rosenberg LLP also provides guidance to individuals with respect to potential criminal liability associated with internal and governmental investigations.  Additionally, we assist in the development of preventive measures designed to avoid criminal liability.

Representative matters:

  • Successfully negotiated an almost unheard of disposition – a strict liability misdemeanor resulting in no jail time or even probation – for a pharmacist charged in the United States District Court for the Southern District of New York with the felony of conspiring to distribute prescription controlled substances.
  • Successfully represented a senior executive of a Fortune 50 corporation in parallel investigations by the U.S. Department of Justice and the Attorney General of the State of New York, resulting in no charges being brought.
  • Persuaded the Public Integrity Unit of the U.S. Department of Justice to terminate without prosecution a three year political corruption investigation of the former chairman of the New York State Republican Party.
  • Represented the former CEO of a multinational bank in an SEC investigation into improprieties in the municipal bond market.
  • Represented senior executives of a “Big Pharma” company in U.S. Department of Justice investigation into marketing practices.
  • Defended the Chief Financial Officer of a major drugstore chain in a securities fraud investigation by the United States Attorney’s Office for the Southern District of New York.

Download PDF »